CNBC Power Lunch December 8, 2014
It is cubist pharmaceuticals. Merck buying the company. Meg terrell was ahead of the story on friday telling us a deal was in the works. She is in San Francisco at one of the biggest cancer meetings of the year and scored a live interview with mercks ceo. Thank you so much. Lets bring in ken frazier, the ceo of merck. Thank you for joining us. Thank you, meg, for having me. Always good to be on cnbc. Well, so this is a big deal in a space that has been a tough area, antibiotics and a Huge Public Health need. Tell us why this makes sense for merck. Every year in this country about 2 Million Peo...